Investors hate uncertainty. If the future of a business or industry is in question, stocks suffer.
That's certainly the case with the biotech sector right now. In 2019, biotech stocks have been pummeled. The Nasdaq Biotech Index is down almost 12% over the last six months.
What's holding back the group? Uncertainty about drug prices is a huge overhang for biotech stocks
Start the conversation
Comment on This Story
Or to contact Money Morning Customer Service, click here.
The Dow Jones today projected a 25-point decline in premarket hours following a report from the U.S. Commerce Department that announced Q2 GDP grew at a rate of 4.1%.
The 4.1% figure is the fastest quarterly growth since July 2014.
Start the conversation
Comment on This Story
Or to contact Money Morning Customer Service, click here.
Recently, our Bill Patalon showed our Members how 21st-century AI technology is helping an ex-FBI agent crack the 20th century's most notorious cold case, and it's one of his favorite profit plays…
Start the conversation